The AKT degrader INY-05-040 outperformed the catalytic inhibitor GDC0068 in suppressing pancreatic cancer cell growth, even though both compounds had comparable suppressive effects on downstream signaling. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.